Justice Department antitrust division looking at health care conglomerates, pharmacy drug middlemen
Newswire
States Keep Legal Pressure on PBMs Ahead of Potential FTC Suit
Drug middlemen say Pharma sets prices. Then why do middlemen have hundreds for the same drug?
CVS Caremark agrees to $45M settlement with Illinois: report
FTC plans to sue top 3 PBMs over insulin prices: WSJ
Medicare Advantage and Consolidation’s New Frontier — The Danger of UnitedHealthcare for All
PBMs pay higher prices to their own pharmacies, FTC says
3Axis Report Scrutinizes PBM Spread Pricing Practice
Mail-Order Drugs Were Supposed to Keep Costs Down. It’s Doing the Opposite.
The Opaque Industry Secretly Inflating Prices for Prescription Drugs
Health-Care Collusion Task Force Sets Stage for DOJ Enforcement
PBM executives invited to testify before House panel
DOJ Launches Task Force on Healthcare Monopolies: Will It Make A Difference?
Mapping the Vertical Integration of Insurers, PBMs, Specialty Pharmacies, and Providers: A May 2024 Update
Mark Cuban has a simple question for CVS’s drug middleman: Why don’t you publish your prices?
Lawmakers slam UnitedHealth chief over Change Healthcare attack
Are below cost reimbursement practices by Pharmacy Benefit Managers creating opportunity for criminals to enter the legitimate supply chain?
Amid increased federal scrutiny, PBMs pivot strategy to further squeeze independent pharmacies
Should the DOJ Break Up UnitedHealth Group?
New reports detail UnitedHealth's latest acquisitions under shady pretenses
We Need Your Support Today!